Proteomic alterations in ovarian cancer—Predicting residual disease status using artificial intelligence and SHAP-based biomarker interpretation
IntroductionHigh-grade serous ovarian cancer (HGSOC) is the most aggressive and prevalent subtype of ovarian Treatment outcomes are significantly influenced by residual disease status following neoadjuvant chemotherapy (NACT). Predicting residual disease before surgery can improve patient stratifica...
Saved in:
| Main Authors: | Seyma Yasar, Rauf Melekoglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1562558/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KLF5-regulated ZDHHC8 reduces chemosensitivity in high-grade serous ovarian cancer through β-catenin signaling
by: Zhuowei Xue, et al.
Published: (2025-07-01) -
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
by: Chuying Huo, et al.
Published: (2024-12-01) -
Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectives
by: Ruiting Fu, et al.
Published: (2025-04-01) -
Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
by: Xuejun Gan, et al.
Published: (2025-03-01) -
MALIGNANT OVARIAN TUMORS AND PREGNANCY
by: Stoyan Stoyanov, et al.
Published: (2022-02-01)